期刊文献+

Genetic, metabolic and environmental factors involved in the development of liver cirrhosis in Mexico 被引量:11

Genetic, metabolic and environmental factors involved in the development of liver cirrhosis in Mexico
下载PDF
导出
摘要 Liver cirrhosis(LC) is a chronic illness caused by inflammatory responses and progressive fibrosis. Globally, the most common causes of chronic liver disease include persistent alcohol abuse, followed by viral hepatitis infections and nonalcoholic fatty liver disease. However, regardless of the etiological factors, the susceptibility and degree of liver damage may be influenced by genetic polymorphisms that are associated with distinct ethnic and cultural backgrounds. Consequently, metabolic genes are influenced by variable environmental lifestyle factors, such as diet, physical inactivity, and emotional stress, which are associated with regional differences among populations. This Topic Highlight will focus on the genetic and environmental factors that may influence the metabolism of alcohol and nutrients in the setting of distinct etiologies of liver disease. The interaction between genes and environment in the current-day admixed population, Mestizo and Native Mexican, will be described. Additionally, genes involved in immune regulation, insulin sensitivity, oxidative stress and extracellular matrix deposition may modulate the degree of severity. In conclusion, LC is a complex disease. The onset, progression, and clinical outcome of LC among the Mexican population are influenced by specific genetic and environmental factors. Among these are an admixed genome with a heterogenic distribution of European, Amerindian and African ancestry; a high score of alcohol consumption; viral infections; a hepatopathogenic diet; and a high prevalence of obesity. The variance in risk factors among populations suggests that intervention strategies directed towards the prevention and management of LC should be tailored according to such population-based features. Liver cirrhosis(LC) is a chronic illness caused by inflammatory responses and progressive fibrosis. Globally, the most common causes of chronic liver disease include persistent alcohol abuse, followed by viral hepatitis infections and nonalcoholic fatty liver disease. However, regardless of the etiological factors, the susceptibility and degree of liver damage may be influenced by genetic polymorphisms that are associated with distinct ethnic and cultural backgrounds. Consequently, metabolic genes are influenced by variable environmental lifestyle factors, such as diet, physical inactivity, and emotional stress, which are associated with regional differences among populations. This Topic Highlight will focus on the genetic and environmental factors that may influence the metabolism of alcohol and nutrients in the setting of distinct etiologies of liver disease. The interaction between genes and environment in the current-day admixed population, Mestizo and Native Mexican, will be described. Additionally, genes involved in immune regulation, insulin sensitivity, oxidative stress and extracellular matrix deposition may modulate the degree of severity. In conclusion, LC is a complex disease. The onset, progression, and clinical outcome of LC among the Mexican population are influenced by specific genetic and environmental factors. Among these are an admixed genome with a heterogenic distribution of European, Amerindian and African ancestry; a high score of alcohol consumption; viral infections; a hepatopathogenic diet; and a high prevalence of obesity. The variance in risk factors among populations suggests that intervention strategies directed towards the prevention and management of LC should be tailored according to such population-based features.
出处 《World Journal of Gastroenterology》 SCIE CAS 2015年第41期11552-11566,共15页 世界胃肠病学杂志(英文版)
基金 Supported by Promep-University of Guadalajara(UDG-CA-478,to Panduro A)
关键词 GENOMIC medicine POLYMORPHISMS VIRAL HEPATITIS Obe Genomic medicine Polymorphisms Viral hepatitis Obe
  • 相关文献

参考文献20

  • 1Rachel H. Westbrook,Geoffrey Dusheiko.Natural history of hepatitis C[J]. Journal of Hepatology . 2014 (1)
  • 2Agata Page,Pier P. Paoli,Stephen J. Hill,Rachel Howarth,Raymond Wu,Soo-Mi Kweon,Jeremy French,Steve White,Hidekazu Tsukamoto,Derek A. Mann,Jelena Mann.Alcohol directly stimulates epigenetic modifications in hepatic stellate cells[J]. Journal of Hepatology . 2014
  • 3Teresa Pollicino,Giovanni Raimondo.Occult hepatitis B infection[J]. Journal of Hepatology . 2014 (3)
  • 4Emmanuel A Tsochatzis,Jaime Bosch,Andrew K Burroughs.Liver cirrhosis[J]. The Lancet . 2014
  • 5Jieliang Chen,Zhenghong Yuan.Interplay between hepatitis B virus and the innate immune responses:implications for new therapeutic strategies[J].Virologica Sinica,2014,29(1):17-24. 被引量:9
  • 6Pu Xia,Mo Zhou,Dao Song Dong,Ya-Nan Xing,Yang Bai.Association of polymorphisms in interleukin-18 and interleukin-28B genes with outcomes of hepatitis B virus infections: a meta-analysis[J]. Tumor Biology . 2014 (2)
  • 7Alfredo Gea,Maira Bes-Rastrollo,Estefania Toledo,Martin Garcia-Lopez,Juan J. Beunza,Ramon Estruch,Miguel A. Martinez-Gonzalez.Mediterranean alcohol-drinking pattern and mortality in the SUN (Seguimiento Universidad de Navarra) Project: a prospective cohort study[J]. British Journal of Nutrition . 2014 (10)
  • 8Erica Novo,Stefania Cannito,Claudia Paternostro,Claudia Bocca,Antonella Miglietta,Maurizio Parola.Cellular and molecular mechanisms in liver fibrogenesis[J]. Archives of Biochemistry and Biophysics . 2013
  • 9Ariane Mallat,Sophie Lotersztajn.Cellular Mechanisms of Tissue Fibrosis. 5. Novel insights into liver fibrosis[J]. AJP: Cell Physiology . 2013 (8)
  • 10Federica Zarrilli,Ausilia Elce,Manuela Scorza,Sonia Giordano,Felice Amato,Giuseppe Castaldo,Fumio Imazeki.An Update on Laboratory Diagnosis of Liver Inherited Diseases[J]. BioMed Research International . 2013

二级参考文献66

  • 1Belloni L, Allweiss L, Guerrieri F, Pediconi N, Volz T, Pollicino T, Petersen J, Raimondo C Dandri M, and Levrero M. 2012. IFN-alpha inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome. J Clin Invest, 122: 529-537.
  • 2Bertoletti A and Ferrari C. 2012. Innate and adaptive immune responses in chronic hepatitis B virus infections: towards resto- ration of immune control of viral infection. Gut, 61: 1754-1764.
  • 3Chang J, Block T M, and Guo J T. 2012. The innate immune response to hepatitis B virus infection: implications for pathogenesis and therapy. Antiviral Res, 96: 405-413.
  • 4Chen J, Zhang W, Lin J, Wang F, Wu M, Chen C, Zheng Y, Per X, Li J, and Yuan Z. 2013. An Efficient Antiviral Strategy f Targeting Hepatitis B Virus Genome Using Transcription Act] vator-Like Effector Nucleases. Mol Ther. doi: 10.1038/mt.2011 212. /.
  • 5Chen J, Wu M, Zhang X, Zhang W, Zhang Z, Chen L, He J, Zheng Y, Chen C, Wang F, Hu Y, Zhou X, Wang C, Xu Y, Lu M, and Yuan Z. 2013. Hepatitis B virus polymerase impairs interferon- alpha-induced STA T activation through inhibition of importin- alpha5 and protein kinase C-delta. Hepatology, 57: 470-482.
  • 6Chen Y, Cheng G, and Mahato R I. 2008. RNAi for treating hepatitis B viral infection. Pharm Res, 25: 72-86.
  • 7chenz' cheng Y, xu Y, Liao J, Zhang )(, Hu Y, Zhang Q, Wang J, Zhang Z, Shen F, and Yuan Z. 2008. Expression profiles and function of Toll-like receptors 2 and 4 in peripheral blood mononuclear cells of chronic hepatitis B patients. Clin Immunol, 128: 400-408.
  • 8Cheng J, Imanishi H, Morisaki H, Liu W, Nakamura H, Morisaki T, and Hada T. 2005. Recombinant HBsAg inhibits LPS-induced COX-2 expression and IL-18 production by interfering with the NFkappaB pathway in a human monocytic cell line, THP-1. J Hepatol, 43: 465-471.
  • 9Christen V, Duong F, Bernsmeier C, Sun D, Nassal M, and Heim M H. 2007. Inhibition of alpha interferon signaling by hepatitis B virus. J Virol, 81: 159-165.
  • 10Cooper A, Tal G; Lider O, and Shaul Y. 2005. Cytokine induction by the hepatitis B virus capsid in.macrophages is facilitated by membrane heparan sulfate and involves TLR2. J Immunol, 175: 3165-3176.

共引文献18

同被引文献76

引证文献11

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部